Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole‐Cell Components of Tumor Tissues or Cells (Adv. Mater. 43/2021). Issue 43 (25th October 2021)

• Record Type: Journal Article
• Authors: Ma, Lin; Diao, Lu; Peng, Zuofu; Jia, Yun; Xie, Huimin; Li, Baisong; Ma, Jianting; Zhang, Meng; Cheng, Lifang; Ding, Dawei; Zhang, Xuenong; Chen, Huabing; Mo, Fengfeng; Jiang, Honglv; Xu, Guoqiang; Meng, Fenghua; Zhong, Zhiyuan; Liu, Mi
• Is Part Of: Advanced materials. Volume 33:Issue 43(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-10-25
• Subjects: cancer immunotherapy -- cancer prevention -- cell lysate -- drug delivery -- nanovaccines -- tumor tissues -- whole cell components; Materials -- Periodicals; Chemical vapor deposition -- Periodicals; 620.11
• DOI: 10.1002/adma.202170341
• Languages: English
• ISSNs: 0935-9648

Abstract

Abstract : Cancer Nanovaccines In article number 2104849, Mi Liu and co‐workers demonstrate a simple and universal method to prepare therapeutic and preventive cancer nanovaccines based on tumor tissues/cells. Such nanovaccines show both potent preventive and potent therapeutic efficacy in lung cancer, melanoma, and breast cancer. This universal method can be applied to make tumor‐cell‐based nanovaccines for cancer immunotherapy and prevention.